Pages that link to "Q33767314"
Jump to navigation
Jump to search
The following pages link to Hematopoietic stem cell transplantation for MDS. (Q33767314):
Displaying 11 items.
- Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends (Q30235355) (← links)
- Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. (Q30353404) (← links)
- Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS. (Q36036263) (← links)
- Current status of allogeneic hematopoietic cell transplantation for MDS. (Q36063049) (← links)
- Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges (Q36266642) (← links)
- Allogeneic hematopoietic cell transplantation for MDS: for whom, when and how? (Q36431041) (← links)
- Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status (Q37964938) (← links)
- Emerging biological therapies for the treatment of myelodysplastic syndromes (Q38834981) (← links)
- Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome. (Q52728073) (← links)
- Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia (Q90059956) (← links)
- Chimeric antigen T cell receptor treatment in hematological malignancies (Q91909940) (← links)